These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 37753074)

  • 1. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
    Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
    Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis.
    Huang XY; Huang ZL; Huang J; Xu B; Huang XY; Xu YH; Zhou J; Tang ZY
    J Exp Clin Cancer Res; 2020 Jan; 39(1):20. PubMed ID: 31973767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells.
    Huang M; Huang X; Huang N
    Cancer Sci; 2022 Jun; 113(6):1968-1983. PubMed ID: 35396771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 5. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.
    Hu Z; Chen G; Zhao Y; Gao H; Li L; Yin Y; Jiang J; Wang L; Mang Y; Gao Y; Zhang S; Ran J; Li L
    Mol Cancer; 2023 Mar; 22(1):55. PubMed ID: 36932387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal circHIF1A derived from hypoxic-induced carcinoma-associated fibroblasts promotes hepatocellular carcinoma cell malignant phenotypes and immune escape.
    Shang H; Lu L; Fan M; Lu Y; Shi X; Lu H
    Int Immunopharmacol; 2024 Sep; 138():112282. PubMed ID: 38936058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma.
    Huang Q; Zhong X; Li J; Hu R; Yi J; Sun J; Xu Y; Zhou X
    Biomed Pharmacother; 2024 Apr; 173():116409. PubMed ID: 38460375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
    Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic stellate cell exosome-derived circWDR25 promotes the progression of hepatocellular carcinoma via the miRNA-4474-3P-ALOX-15 and EMT axes.
    Liu L; Liao R; Wu Z; Du C; You Y; Que K; Duan Y; Yin K; Ye W
    Biosci Trends; 2022 Sep; 16(4):267-281. PubMed ID: 35934785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
    Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
    Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances of exosomal circRNAs in cancer and their potential clinical applications.
    Yi Q; Yue J; Liu Y; Shi H; Sun W; Feng J; Sun W
    J Transl Med; 2023 Jul; 21(1):516. PubMed ID: 37525158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.
    Zhang L; Zhang J; Li P; Li T; Zhou Z; Wu H
    Cell Death Dis; 2022 Jan; 13(1):32. PubMed ID: 35013102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal microRNAs in hepatocellular carcinoma, expanding research field.
    Zheng BH; Ni XJ; Liu HB
    World J Gastroenterol; 2024 May; 30(20):2618-2620. PubMed ID: 38855155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
    Wu MN; Sun JY; Yao M; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant CircRNAs in liver cancer stem cell exosomes: mediator of malignant propagation in liver cancer?
    Han T; Chen L; Li K; Hu Q; Zhang Y; You X; Han L; Chen T; Li K
    Mol Cancer; 2023 Dec; 22(1):197. PubMed ID: 38053070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
    Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
    World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.
    Xu Z; Chen Y; Ma L; Chen Y; Liu J; Guo Y; Yu T; Zhang L; Zhu L; Shu Y
    Mol Ther; 2022 Oct; 30(10):3133-3154. PubMed ID: 35405312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
    Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
    Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.